Navigation Links
Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Date:7/22/2008

liquid form, provides an alternative pathway to the urea cycle for the disposal of waste nitrogen through the renal excretion of phenylacetylglutamine, which is formed from PAA and glutamine.

About BUPHENYL(R)

BUPHENYL(R) is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). BUPHENYL(R) should not be administered to patients with known hypersensitivity to sodium phenylbutyrate or any component of this preparation. The most common adverse reactions associated with BUPHENYL(R) were amenorrhea dysfunction, decreased appetite, body odor (probably caused by its metabolite phenylacetate) and bad taste or taste aversion. Patients with urea cycle disorders should not take valproic acid, haloperidol, or steroids as these drugs have been reported to increase blood ammonia levels, and probenecid may affect the kidneys' excretion. Use with great care, if at all, in patients with congestive heart failure or severe renal insufficiency, and in clinical states where there is sodium retention with edema. Use caution when administering to patients with hepatic or renal insufficiency or inborn errors of beta oxidation. The safety or efficacy of doses in excess of 20 grams (40 tablets) per day has not been established.

About Hyperion Therapeutics

Hyperion Therapeutics is a specialty therapeutics company focused on the development of therapies that address orphan or underserved patient populations with unmet medical needs. Hyperion is headquartered in South San Francisco, CA. For additional information, visit: http://www.hyperiontx.com.

BUPHENYL is a registered trademark of Ucyclyd Pharma, Inc.

Full Prescribing Information for BUPHENYL(R) is available at http://www.
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients With Urea Cycle Disorders
2. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ... of injectable drug delivery systems, today announced the launch ... The new site includes additional products, videos, features, blogs ... regular basis. Mr. Alan Shortall , ... leader for injectable drug delivery systems, we have created ...
(Date:6/18/2013)... 18, 2013 MPR is excited to unveil ... edition. It,s all part of an ongoing effort to freshen ... practitioners for over 28 years. (Photo: ... evolution MPR has expanded upon its foundation as ... to include an increasing array of clinical and practice management ...
(Date:6/18/2013)... June 18, 2013 New-generation electronic designs ... portable and lightweight. Simultaneously, circuitry is increasing the ... speed to which it performs at. Connecting cables ... and military equipment, such as cameras or detectors, ... and nano-circular connectors include custom cable designs for ...
Breaking Medicine Technology:Unilife Launches New Corporate Website 2MPR Sports a Bold New Look 2Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2
(Date:6/18/2013)... As obesity rates sky rocket in the United States and ... comes as no shock. Forceps are surgical equipment used to ... unable to do so herself and although they are useful ... complication for both the mother and the baby. , ... forceps births add to the pressure of healthcare providers, including ...
(Date:6/18/2013)... Albany, New York (PRWEB) June 19, 2013 ... provides comprehensive understanding and unprecedented access to the drug ... worlds leading healthcare companies. , The report provides ... companies enter drug delivery partnering deals. The majority of ... obtains a right or an option right to license ...
(Date:6/18/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, reports that ... Infuse bone graft products are now available. Published this ... the two studies serve up two key findings: There ... Infuse and the traditional bone graft; and there is ...
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 ENT ... to grow in size. Quite the opposite. , ... audiology practice-with over 140 expertly trained physicians offering superior ... in 40 locations throughout the Greater New York area-only ... important circumstances are right. And that includes the right ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... Magnum hip continue to move forward in a multidistrict ... Bernstein Liebhard LLP reports. According to court records, ... June 17th, at which time the Court also convened ... and technical issues pertinent to the Biomet hip replacement ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3
... Medicare bidding,program for durable medical equipment will hurt ... Congress modifies,the program. This is the key message ... by the American Association for Homecare.,The Association believes ... choice of provider, and access to the medical ...
... To Those With Chronic Diseases In California To Help Ensure ... ... (NYSE: WLP ),continues to reach out to victims of the southern ... areas, longer,lasting health implications are beginning to take root, impacting all,residents, but ...
... de Latinos Unidos, a,U.S. not-for-profit organization and public ... government officials of the Mexican State,of Sonora disclosed ... an,international investigative study focusing on immigrant "dumping" which,began ... practice of U.S. employers and others who,simply deport ...
... Inc. (Nasdaq: BDSI, http://www.biodeliverysciences.com ) has submitted ... Food and Drug Administration (FDA) for BEMATM Fentanyl, ... The filing of the NDA represents a progression ... BDSIs lead product, including the April 2007 announcement ...
... 31 According to a national,online survey administered by ... of patients diagnosed with methicillin-resistant,staphylococcus aureus (MRSA) reported that ... time of diagnosis. More than 80% of 312 ... care provider on ways to avoid spreading MRSA to ...
... of dying of the disease in half when they ... compared to those who dont receive active treatment (watchful ... localized prostate cancer, according to a study presented October ... and Oncologys 49th Annual Meeting in Los Angeles. , ...
Cached Medicine News:Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 2Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 3Health News:WellPoint Provides Support and Resources to Most Vulnerable California Residents 2Health News:WellPoint Provides Support and Resources to Most Vulnerable California Residents 3Health News:Latino Advocacy Group Investigates Immigrant 'Dumping' by U.S. Employers 2Health News:BDSI files FDA NDA for BEMA Fentanyl 2Health News:BDSI files FDA NDA for BEMA Fentanyl 3Health News:New Survey Finds that over Half of MRSA Patients Report Having Received No Information about the Disease from Health Care Providers 2Health News:New Survey Finds that over Half of MRSA Patients Report Having Received No Information about the Disease from Health Care Providers 3Health News:Radiation seed implant decreases risk of death over watchful waiting 2
1-Day Acuvue brand contact lenses offer the healthiest, most convenient way to wear contact lenses. There's no lens care or messy solutions required, just wear them one day and throw them away....
... Magellan Mapper connects via a ... or desktop computer featuring Windows ... state of the art corneal ... bright ring projection and easy ...
... Oculus Easygraph is a corneal topographer ... you need for refractive surgery, contact ... contact lens fitting in a small ... package. All you need to supply ...
Available in 10 beautiful opaque colors....
Medicine Products: